Skip to main content
NCBI home page
Infection and Immunity logoLink to Infection and Immunity
. 1996 Nov;64(11):4726–4732. doi: 10.1128/iai.64.11.4726-4732.1996

Analysis of complement C3 deposition and degradation on Klebsiella pneumoniae.

S Albertí 1, D Alvarez 1, S Merino 1, M T Casado 1, F Vivanco 1, J M Tomás 1, V J Benedí 1
PMCID: PMC174438  PMID: 8890232

Abstract

The majority of Klebsiella pneumoniae serum-resistant strains activate complement and bind C3b, the opsonic fragment of C3, without C5b-9 formation and bacterial killing. The mechanisms leading to C3b deposition without cell death were studied, and the results indicate that serum-resistant strains activate principally the alternative pathway and that serum-sensitive strains activate both the alternative and classical pathways. Bacterial molecules implicated in C3b deposition are the outer membrane porin proteins and smooth and rough lipopolysaccharides. Porins activate both complement pathways, and the rough lipopolysaccharide activates the classical pathway, causing deposition of C3b in serum-sensitive strains. The smooth lipopolysaccharide of serum-resistant strains activates only the alternative pathway, impeding the binding of C1q to porins (S. Albertí, G. Marqués, S. Camprubí, S. Merino, J. M. Tomás, F. Vivanco, and V. J. Benedí, Infect. Immun. 61:852-860, 1993; S. Albertí, F. Rodríguez-Quinónes, T. Schirmer, G. Rummel, J. M. Tomás, J. P. Rosenbusch, and V. J. Benedí, Infect. Immun. 63:903-910, 1995) and rough lipopolysaccharide molecules and thereby preventing activation of the classical pathway. After its deposition, C3b is quickly degraded to iC3b on both types of strains, but the higher-level deposition of C3b on serum-sensitive strains, resulting from activation of both the alternative and classical complement pathways, supports further complement activation and killing of serum-sensitive strains.

Full Text

The Full Text of this article is available as a PDF (251.5 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Albertí S., Marqués G., Camprubí S., Merino S., Tomás J. M., Vivanco F., Benedí V. J. C1q binding and activation of the complement classical pathway by Klebsiella pneumoniae outer membrane proteins. Infect Immun. 1993 Mar;61(3):852–860. doi: 10.1128/iai.61.3.852-860.1993. [DOI] [PMC free article] [PubMed] [Google Scholar]
  2. Albertí S., Rodríquez-Quiñones F., Schirmer T., Rummel G., Tomás J. M., Rosenbusch J. P., Benedí V. J. A porin from Klebsiella pneumoniae: sequence homology, three-dimensional model, and complement binding. Infect Immun. 1995 Mar;63(3):903–910. doi: 10.1128/iai.63.3.903-910.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Antón L. C., Alcolea J. M., Sánchez-Corral P., Marqués G., Sánchez A., Vivanco F. C3 binds covalently to the C gamma 3 domain of IgG immune aggregates during complement activation by the alternative pathway. Biochem J. 1989 Feb 1;257(3):831–838. doi: 10.1042/bj2570831. [DOI] [PMC free article] [PubMed] [Google Scholar]
  4. Benedí V. J., Ciurana B., Tomás J. M. Isolation and characterization of Klebsiella pneumoniae unencapsulated mutants. J Clin Microbiol. 1989 Jan;27(1):82–87. doi: 10.1128/jcm.27.1.82-87.1989. [DOI] [PMC free article] [PubMed] [Google Scholar]
  5. Benge G. R. Bactericidal activity of human serum against strains of Klebsiella from different sources. J Med Microbiol. 1988 Sep;27(1):11–15. doi: 10.1099/00222615-27-1-11. [DOI] [PubMed] [Google Scholar]
  6. Blake M. S., Johnston K. H., Russell-Jones G. J., Gotschlich E. C. A rapid, sensitive method for detection of alkaline phosphatase-conjugated anti-antibody on Western blots. Anal Biochem. 1984 Jan;136(1):175–179. doi: 10.1016/0003-2697(84)90320-8. [DOI] [PubMed] [Google Scholar]
  7. Bodey G. P., Elting L. S., Rodriquez S., Hernandez M. Klebsiella bacteremia. A 10-year review in a cancer institution. Cancer. 1989 Dec 1;64(11):2368–2376. doi: 10.1002/1097-0142(19891201)64:11<2368::aid-cncr2820641129>3.0.co;2-h. [DOI] [PubMed] [Google Scholar]
  8. Ciurana B., Tomás J. M. Role of lipopolysaccharide and complement in susceptibility of Klebsiella pneumoniae to nonimmune serum. Infect Immun. 1987 Nov;55(11):2741–2746. doi: 10.1128/iai.55.11.2741-2746.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Filip C., Fletcher G., Wulff J. L., Earhart C. F. Solubilization of the cytoplasmic membrane of Escherichia coli by the ionic detergent sodium-lauryl sarcosinate. J Bacteriol. 1973 Sep;115(3):717–722. doi: 10.1128/jb.115.3.717-722.1973. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Fine D. P. Comparison of ethyleneglycoltetraacetic acid and its magnesium salt as reagents for studying alternative complement pathway function. Infect Immun. 1977 Apr;16(1):124–128. doi: 10.1128/iai.16.1.124-128.1977. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Galdiero F., Tufano M. A., Sommese L., Folgore A., Tedesco F. Activation of complement system by porins extracted from Salmonella typhimurium. Infect Immun. 1984 Nov;46(2):559–563. doi: 10.1128/iai.46.2.559-563.1984. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. García de la Torre M., Romero-Vivas J., Martínez-Beltrán J., Guerrero A., Meseguer M., Bouza E. Klebsiella bacteremia: an analysis of 100 episodes. Rev Infect Dis. 1985 Mar-Apr;7(2):143–150. doi: 10.1093/clinids/7.2.143. [DOI] [PubMed] [Google Scholar]
  13. Gordon D. L., Rice J., Finlay-Jones J. J., McDonald P. J., Hostetter M. K. Analysis of C3 deposition and degradation on bacterial surfaces after opsonization. J Infect Dis. 1988 Apr;157(4):697–704. doi: 10.1093/infdis/157.4.697. [DOI] [PubMed] [Google Scholar]
  14. Hancock R. E., Nikaido H. Outer membranes of gram-negative bacteria. XIX. Isolation from Pseudomonas aeruginosa PAO1 and use in reconstitution and definition of the permeability barrier. J Bacteriol. 1978 Oct;136(1):381–390. doi: 10.1128/jb.136.1.381-390.1978. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Hervás J. A., Alomar A., Salvá F., Reina J., Benedí V. J. Neonatal sepsis and meningitis in Mallorca, Spain, 1977-1991. Clin Infect Dis. 1993 May;16(5):719–724. doi: 10.1093/clind/16.5.719. [DOI] [PubMed] [Google Scholar]
  16. Hostetter M. K., Gordon D. L. Biochemistry of C3 and related thiolester proteins in infection and inflammation. Rev Infect Dis. 1987 Jan-Feb;9(1):97–109. doi: 10.1093/clinids/9.1.97. [DOI] [PubMed] [Google Scholar]
  17. Joiner K. A., Brown E. J., Frank M. M. Complement and bacteria: chemistry and biology in host defense. Annu Rev Immunol. 1984;2:461–491. doi: 10.1146/annurev.iy.02.040184.002333. [DOI] [PubMed] [Google Scholar]
  18. Joiner K. A., Grossman N., Schmetz M., Leive L. C3 binds preferentially to long-chain lipopolysaccharide during alternative pathway activation by Salmonella montevideo. J Immunol. 1986 Jan;136(2):710–715. [PubMed] [Google Scholar]
  19. LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
  20. Merino S., Camprubí S., Albertí S., Benedí V. J., Tomás J. M. Mechanisms of Klebsiella pneumoniae resistance to complement-mediated killing. Infect Immun. 1992 Jun;60(6):2529–2535. doi: 10.1128/iai.60.6.2529-2535.1992. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Nikaido H. Proteins forming large channels from bacterial and mitochondrial outer membranes: porins and phage lambda receptor protein. Methods Enzymol. 1983;97:85–100. doi: 10.1016/0076-6879(83)97122-7. [DOI] [PubMed] [Google Scholar]
  22. Praz F., Roque Antunes Barreira M. C., Lesavre P. A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum. J Immunol Methods. 1982;50(2):227–231. doi: 10.1016/0022-1759(82)90229-0. [DOI] [PubMed] [Google Scholar]
  23. Sánchez-Corral P., Antón L. C., Alcolea J. M., Marqués G., Sánchez A., Vivanco F. Separation of active and inactive forms of the third component of human complement, C3, by fast protein liquid chromatography (FPLC). J Immunol Methods. 1989 Aug 15;122(1):105–113. doi: 10.1016/0022-1759(89)90340-2. [DOI] [PubMed] [Google Scholar]
  24. Taylor P. W. Bactericidal and bacteriolytic activity of serum against gram-negative bacteria. Microbiol Rev. 1983 Mar;47(1):46–83. doi: 10.1128/mr.47.1.46-83.1983. [DOI] [PMC free article] [PubMed] [Google Scholar]
  25. Tomas J. M., Camprubi S., Williams P. Surface exposure of the O-antigen in Klebsiella pneumoniae O1:K1 serotype strains. Microb Pathog. 1988 Aug;5(2):141–147. doi: 10.1016/0882-4010(88)90016-2. [DOI] [PubMed] [Google Scholar]
  26. Tomás J. M., Benedí V. J., Ciurana B., Jofre J. Role of capsule and O antigen in resistance of Klebsiella pneumoniae to serum bactericidal activity. Infect Immun. 1986 Oct;54(1):85–89. doi: 10.1128/iai.54.1.85-89.1986. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Towbin H., Staehelin T., Gordon J. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci U S A. 1979 Sep;76(9):4350–4354. doi: 10.1073/pnas.76.9.4350. [DOI] [PMC free article] [PubMed] [Google Scholar]
  28. Tsai C. M., Frasch C. E. A sensitive silver stain for detecting lipopolysaccharides in polyacrylamide gels. Anal Biochem. 1982 Jan 1;119(1):115–119. doi: 10.1016/0003-2697(82)90673-x. [DOI] [PubMed] [Google Scholar]
  29. Tsai C. M. The analysis of lipopolysaccharide (endotoxin) in meningococcal polysaccharide vaccines by silver staining following SDS-polyacrylamide gel electrophoresis. J Biol Stand. 1986 Jan;14(1):25–33. doi: 10.1016/s0092-1157(86)80006-3. [DOI] [PubMed] [Google Scholar]
  30. Vivanco-Martínez F., Bragado R., Albar J. P., Juarez C., Ortíz-Masllorens F. Chemical modification of carboxyl groups in human Fc gamma fragments: structural role and effect on the complement fixation. Mol Immunol. 1980 Mar;17(3):327–336. doi: 10.1016/0161-5890(80)90053-x. [DOI] [PubMed] [Google Scholar]
  31. Vukajlovich S. W., Hoffman J., Morrison D. C. Activation of human serum complement by bacterial lipopolysaccharides: structural requirements for antibody independent activation of the classical and alternative pathways. Mol Immunol. 1987 Apr;24(4):319–331. doi: 10.1016/0161-5890(87)90173-8. [DOI] [PubMed] [Google Scholar]
  32. Williams P., Ciurana B., Camprubi S., Tomas J. M. Influence of lipopolysaccharide chemotype on the interaction between Klebsiella pneumoniae and human polymorphonuclear leucocytes. FEMS Microbiol Lett. 1990 Jun 1;57(3):305–309. doi: 10.1016/0378-1097(90)90085-5. [DOI] [PubMed] [Google Scholar]

Articles from Infection and Immunity are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES